Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era

BACKGROUND: The International Prognostic Index (IPI) has been a useful tool for predicting the prognosis of aggressive non-Hodgkin lymphoma in the last 20 years. Herein, we aimed to develop a new prognostic model for diffuse large B-cell lymphoma (DLBCL) in the rituximab era. METHODS: Between March...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jihoon, Yoon, Shinkyo, Suh, Cheolwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762738/
https://www.ncbi.nlm.nih.gov/pubmed/29333404
http://dx.doi.org/10.5045/br.2017.52.4.276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762738/
https://www.ncbi.nlm.nih.gov/pubmed/29333404
http://dx.doi.org/10.5045/br.2017.52.4.276

Ejemplares similares